Dr. Gerard C. Blobe, MD

Dr. Blobe practices at Duke University Hospital in Durham, North Carolina, part of Duke University.

Dr. Blobe's NPI, 1184694754, was assigned on January 25, 2006. Dr. Blobe graduated from Duke University School of Medicine in 1995.

Dr. Blobe's primary practice is Duke University Hospital, at 2301 Erwin Rd, Durham, NC 27705 in Durham County. The practice phone is (919) 684-8111.

Dr. Blobe's primary practice is Duke University Hospital in Durham, North Carolina, part of Duke University. The medical group on file is Duke Health Integrated Practice.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Blobe practices. Vendor and product names are available with a free account.

Medical oncology is Dr. Blobe's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Blobe has a license on file in North Carolina.

CMS data shows 430 Medicare services from Dr. Blobe across 5 procedure codes in 2024, for 93 Medicare patients. Medicare paid $27,767 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 93 Medicare patients who saw Dr. Blobe in 2024. The largest group is 65 to 74, with 44 patients. 71% of them have high cholesterol, and 70% have high blood pressure. Their average risk score is 2.29, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Blobe's median patient age at 73, with 50% women.

In 2024, Dr. Blobe wrote 195 Medicare Part D claims for 51 patients. 86% of them were for generic drugs. CMS names the drug for 104 of them, across 5 drugs with 11 or more claims each, at $76,812 in total drug cost. In 2023, CMS named 47 claims across 3 drugs.

Dr. Blobe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Blobe as offering telehealth.

Dmand AI links 43 papers to Dr. Blobe, published from 2010 to 2024. 2013 was the busiest year, with 7. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Antibodies, Monoclonal, Humanized and Bevacizumab. Dr. Blobe has published most often in Cancer Chemother Pharmacol. Dr. Blobe's most frequent co-authors are Herbert Hurwitz, MD, Hope Elizabeth Uronis, MD and Syed Yousuf Zafar, MD.

Dmand AI links Dr. Blobe to 1 clinical trial. Conditions studied include Krukenberg Tumor and Carcinoma, Signet Ring Cell.

CMS Open Payments shows 69 general payments to Dr. Blobe from 2 drug and device companies from 2016 to 2018. Speaker and faculty fees make up the largest share, 85% of the total. Genentech, Inc. paid the most, $86,999.

Dr. Blobe graduated from Duke University School of Medicine in 1995.